Today we’re talking about the zebrafish at MSK, you can learn more about them here!
Graduation, $1.3 Million Raised at Wall Street Decathlon and More …
- June is a month where graduations abound. On Thursday, June 11, a group of teenage cancer patients celebrated at MSK after graduating from high school. The New York Daily News reported on this special event.
- Bloomberg Business reports that this year’s annual Wall Street Decathlon, held the weekend of June 13 – June 14 in New York City, raised approximately $1.3 million for cancer research for MSK. More than $6.3 million for cancer research has been raised since the decathlon started in 2009.
- A recent online article in the San Francisco Business Times, discusses the licensing deal between Atara Biotherapeutics and MSK for “experimental off-the-shelf cell therapies against cancer and long term viral infections.”
- MSK’s Dr. Jedd D. Wolchok and colleague Dr. Michael A. Postow, are featured in an online June 22 OncLive article, that discusses study results recently presented at the 2015 American Society of Clinical Oncology’s Annual Meeting.
Award-Winning Micro-Device Technology Could Eliminate Need for Animal Testing
Scientists at Harvard University’s Wyss Institute have created silicon chips that mimic the function of living human organs. Their organs-on-chips technology won the 2015 Design of the Year award from the Design Museum in London. It’s the first time the award has gone to a design from the field of medicine, beating off competition from Google’s self-driving car, a project to clean up plastic from the sea and an advertising campaign to convince people to buy misshapen fruit. The micro-devices work by recreating the tissue interfaces of human organs inside a transparent polymer “chip,” so the behaviors of bacteria, drugs and human white blood cells can be easily monitored through a microscope. These new devices could end animal testing and revolutionize the development of new drugs. Learn more at the Wyss Institute.